A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
E Silberstein, C Serna, SP Fragoso, R Nagarkatti… - PLoS …, 2018 - journals.plos.org
Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8–10
million people worldwide and represents a major public health challenge. There is no …
million people worldwide and represents a major public health challenge. There is no …
In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection
C Henriques, A Henriques-Pons, M Meuser-Batista… - Parasites & vectors, 2014 - Springer
Background The development of techniques that allow the imaging of animals infected with
parasites expressing luciferase opens up new possibilities for following the fate of parasites …
parasites expressing luciferase opens up new possibilities for following the fate of parasites …
Bioluminescent imaging of Trypanosoma cruzi infection
KV Hyland, SH Asfaw, CL Olson, MD Daniels… - International journal for …, 2008 - Elsevier
Chagas disease, caused by infection with the protozoan parasite Trypanosoma cruzi, is a
major public health problem in Central and South America. The pathogenesis of Chagas …
major public health problem in Central and South America. The pathogenesis of Chagas …
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers …
AF Francisco, U Saade, S Jayawardhana… - PLoS neglected …, 2022 - journals.plos.org
Background Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and is
a serious public health problem throughout Latin America. With 6 million people infected …
a serious public health problem throughout Latin America. With 6 million people infected …
A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
The protozoan Trypanosoma cruzi is the causative agent of Chagas disease, one of the
world's major neglected infections. Although development of improved antiparasitic drugs is …
world's major neglected infections. Although development of improved antiparasitic drugs is …
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions
MC Taylor, AF Francisco, S Jayawardhana… - T. cruzi Infection …, 2019 - Springer
Trypanosoma cruzi is the causative agent of Chagas disease, the most important parasitic
infection in Latin America. Despite a global research effort, there have been no significant …
infection in Latin America. Despite a global research effort, there have been no significant …
Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase
AP McLatchie, H Burrell-Saward… - PLoS neglected …, 2013 - journals.plos.org
Background Human African trypanosomiasis is caused by infection with parasites of the
Trypanosoma brucei species complex, and threatens over 70 million people in sub-Saharan …
Trypanosoma brucei species complex, and threatens over 70 million people in sub-Saharan …
A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research
F Olmo, S Jayawardhana, AA Khan… - PLOS Neglected …, 2024 - journals.plos.org
Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite that displays
considerable genetic diversity. Infections result in a range of pathological outcomes, and …
considerable genetic diversity. Infections result in a range of pathological outcomes, and …
Bioluminescent imaging of Trypanosoma cruzi infection in Rhodnius prolixus
Background Usually the analysis of the various developmental stages of Trypanosoma cruzi
in the experimentally infected vertebrate and invertebrate hosts is based on the …
in the experimentally infected vertebrate and invertebrate hosts is based on the …
In Situ Detection of Dormant Trypanosoma cruzi Amastigotes Using Bioluminescent-Fluorescent Reporters
F Sánchez-Valdéz, A Padilla - T. cruzi Infection: Methods and Protocols, 2019 - Springer
Chagas disease agent, Trypanosoma cruzi, is capable to persist after prolonged drug
treatment using effective drugs. The reason of treatment failure is not known, but recent …
treatment using effective drugs. The reason of treatment failure is not known, but recent …